MSB 2.17% $1.13 mesoblast limited

According to today's Financial Times: Merck chief executive Ken...

  1. 603 Posts.
    lightbulb Created with Sketch. 292
    According to today's Financial Times:
    Merck chief executive Ken Frazier has cast doubt on the 12 to 18-month timeframe to develop an effective coronavirus vaccine, describing the widely mooted schedule as “very aggressive”.“It is not something I would put out there that I would want to hold Merck to,” the US pharmaceutical group’s chief told the Financial Times, adding that vaccines should be tested in “very large” clinical trials that take several months if not years to complete.“You want to make sure that when you put a vaccine into millions if not billions of people, it is safe,” he said.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.